- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-IL5 therapy for asthma and beyond
Authors
Keywords
Eosinophil, IL-5, Eosinophilic asthma, Hypereosinophilic syndrome (HES), Churg-strauss syndrome, Chronic bronchitis, Eosinophilic granulamatosis and polyangitis (EGPA), Chronic obstructive pulmonary disorder (COPD), Mepolizumab, Reslizumab, Benralizumab
Journal
World Allergy Organization Journal
Volume 7, Issue 1, Pages 1-15
Publisher
Springer Nature
Online
2014-12-04
DOI
10.1186/1939-4551-7-32
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of mepolizumab in atopic and nonatopic severe asthma with persistent eosinophilia
- (2014) H. Ortega et al. EUROPEAN RESPIRATORY JOURNAL
- Innate lymphoid cells and asthma
- (2014) Sanhong Yu et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Anti–Interleukin-5 Monoclonal Antibody to Treat Severe Eosinophilic Asthma
- (2014) Parameswaran Nair NEW ENGLAND JOURNAL OF MEDICINE
- Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
- (2014) Elisabeth H. Bel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
- (2014) Hector G. Ortega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): state of the art
- (2013) A. Vaglio et al. ALLERGY
- The consequences of not having eosinophils
- (2013) G. J. Gleich et al. ALLERGY
- Targeting Interleukin-5 in Refractory and Relapsing Churg–Strauss Syndrome
- (2013) Frank Moosig et al. ANNALS OF INTERNAL MEDICINE
- Safety and efficacy of an oral CCR3 antagonist in patients with asthma and eosinophilic bronchitis: a randomized, placebo-controlled clinical trial
- (2013) H. Neighbour et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Development and function of group 2 innate lymphoid cells
- (2013) Jennifer A Walker et al. CURRENT OPINION IN IMMUNOLOGY
- Monoclonal antibodies for the treatment of refractory asthma
- (2013) Nathan Hambly et al. CURRENT OPINION IN PULMONARY MEDICINE
- What is an “eosinophilic phenotype” of asthma?
- (2013) Parameswaran Nair JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia
- (2013) Michel Laviolette et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- TH2, allergy and group 2 innate lymphoid cells
- (2013) Paula Licona-Limón et al. NATURE IMMUNOLOGY
- Eosinophils in the Spotlight: Eosinophilic airway inflammation in nonallergic asthma
- (2013) Guy G Brusselle et al. NATURE MEDICINE
- Dupilumab in Persistent Asthma with Elevated Eosinophil Levels
- (2013) Sally Wenzel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeted therapy of bronchitis in obstructive airway diseases
- (2013) Angira Dasgupta et al. PHARMACOLOGY & THERAPEUTICS
- Eosinophilic Pneumonias
- (2012) P. Akuthota et al. CLINICAL MICROBIOLOGY REVIEWS
- How to Diagnose and Phenotype Asthma
- (2012) Parameswaran Nair et al. CLINICS IN CHEST MEDICINE
- Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
- (2012) Ian D Pavord et al. LANCET
- The potential of biologics for the treatment of asthma
- (2012) Girolamo Pelaia et al. NATURE REVIEWS DRUG DISCOVERY
- Reslizumab for Poorly Controlled, Eosinophilic Asthma
- (2011) Mario Castro et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Interleukin-4 and interleukin-13 prime migrational responses of haemopoietic progenitor cells to stromal cell-derived factor-1α
- (2011) N. Punia et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Benralizumab – a humanized mAb to IL-5Rα with enhanced antibody-dependent cell-mediated cytotoxicity – a novel approach for the treatment of asthma
- (2011) Aasia Ghazi et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Eosinophils in health and disease: the LIAR hypothesis
- (2010) J. J. Lee et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti–IL-5 receptor α antibody, in a phase I study of subjects with mild asthma
- (2010) William W. Busse et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Sustained response to mepolizumab in refractory Churg-Strauss syndrome
- (2010) Jean-Emmanuel Kahn et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- A review of treatment with mepolizumab, an anti–IL-5 mAb, in hypereosinophilic syndromes and asthma
- (2010) William W. Busse et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Mepolizumab as a corticosteroid-sparing agent in lymphocytic variant hypereosinophilic syndrome
- (2010) Florence Roufosse et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome
- (2010) Sophia Kim et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Human airway smooth muscle promotes eosinophil differentiation
- (2009) A. I. Fanat et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
- (2009) Pranabashis Haldar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia
- (2009) Parameswaran Nair et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antisense Therapy against CCR3 and the Common Beta Chain Attenuates Allergen-induced Eosinophilic Responses
- (2008) Gail M. Gauvreau et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Treatment of Patients with the Hypereosinophilic Syndrome with Mepolizumab
- (2008) Marc E. Rothenberg et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started